Evidence map›Paper›PMID 24209627›Full record

ArticleCell2013

A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.

Cong Xu, Mohammadsharif Tabebordbar, Salvatore Iovino, Christie Ciarlo, Jingxia Liu, Alessandra Castiglioni, Emily Price, Min Liu, Elisabeth R Barton, C Ronald Kahn and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 169 citations in OpenAlex.

  1. Article
  2. In Vitro Hatching ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Cong Xu *Division of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Mohammadsharif Tabebordbar *Howard Hughes Medical Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA.
Salvatore Iovino *Harvard Medical School, Boston, MA 02115, USA.
Christie CiarloDivision of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Jingxia LiuDivision of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Alessandra CastiglioniHoward Hughes Medical Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA.
Emily PriceDivision of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Min LiuDepartment of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Elisabeth R BartonDepartment of Anatomy and Cell Biology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
C Ronald KahnHarvard Medical School, Boston, MA 02115, USA.
Amy J WagersHoward Hughes Medical Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA.
Leonard I ZonDivision of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Harvard University · USHarvard Stem Cell Institute · USJoslin Diabetes Center · USUniversity of Pennsylvania · USDana-Farber Cancer Institute · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
CORE--ZEBRAFISHP30DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1999 to 2015
$14.3M
INSULIN RECEPTOR STRUCTURE AND TURNOVERR37DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2000 to 2019
$12.9M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
Microenvironmental control of progenitors in organ dysfunction and repairU01HL100402 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI KIM, CARLA F., SCADDEN, DAVID T · 2009 to 2015
$8.5M
Role of PI 3-Kinase Isoforms in Insulin ActionR01DK055545 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1999 to 2020
$8.3M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
EMBRYONIC HEMATOPOIESISR01HL048801 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1992 to 2016
$5.7M
The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
Aging and Rejuvenation of the hematopoietic stem cell nicheDP2OD004345 · OD · JOSLIN DIABETES CENTER · PI WAGERS, AMY JO · 2008 to 2008
$2.4M
Howard Hughes Medical InstituteNCI NIH HHS 5R01CA103846-10NCI NIH HHS R01 CA103846NHLBI NIH HHS 5U01HL10001-05NHLBI NIH HHS R01 HL048801NHLBI NIH HHS U01 HL100402NHLBI NIH HHS UO1HL100402NIAMS NIH HHS U54 AR052646NIDDK NIH HHS 5P30 DK49216-19NIDDK NIH HHS DK31036NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK049216NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK055545NIDDK NIH HHS R24 DK092760NIDDK NIH HHS R24DK092760-03NIDDK NIH HHS R37 DK031036NIH HHS DP2 OD004345NIH HHS DP2OD004345
6 · The paper itself

Abstract

Ex vivo expansion of satellite cells and directed differentiation of pluripotent cells to mature skeletal muscle have proved difficult challenges for regenerative biology. Using a zebrafish embryo culture system with reporters of early and late skeletal muscle differentiation, we examined the influence of 2,400 chemicals on myogenesis and identified six that expanded muscle progenitors, including three GSK3β inhibitors, two calpain inhibitors, and one adenylyl cyclase activator, forskolin. Forskolin also enhanced proliferation of mouse satellite cells in culture and maintained their ability to engraft muscle in vivo. A combination of bFGF, forskolin, and the GSK3β inhibitor BIO induced skeletal muscle differentiation in human induced pluripotent stem cells (iPSCs) and produced engraftable myogenic progenitors that contributed to muscle repair in vivo. In summary, these studies reveal functionally conserved pathways regulating myogenesis across species and identify chemical compounds that expand mouse satellite cells and differentiate human iPSCs into engraftable muscle.

Indexed as

Drug Evaluation, PreclinicalAnimalsColforsinCulture TechniquesCyclic AMPInduced Pluripotent Stem CellsMiceMuscle DevelopmentMuscle, SkeletalMuscular DystrophiesSatellite Cells, Skeletal MuscleStem Cell TransplantationZebrafishColforsinCyclic AMP

Identifiers

PMID24209627
PMCPMC3902670
OpenAlexW1971436489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.